Cannabis Control Commission Public Meeting
In accordance with Sections 18-25 of Chapter 30A of the Massachusetts General Laws, notice is hereby given of a meeting of the Cannabis Control Commission:
December 13, 2018
1:00pm
Location:
Massachusetts State House, Room A-1
24 Beacon Street
Boston, MA 02133
In-Person with Remote Access via Microsoft Teams Live*
Public Meeting Agenda
1) Call to Order
2) Chairman’s Comments & Updates
3) Minutes
4) Executive Director’s Report
a) License Applications
5) Staff Recommendations on Final Licenses
a) Alternative Therapies Group, Inc. (# MC281255), Cultivation, Tier 5/Indoor
b) Alternative Therapies Group, Inc. (# MP281300), Product Manufacturer
c) Northeast Alternatives, Inc. (# MC281319), Cultivation, Tier 1/Indoor Operation
d) Northeast Alternatives, Inc. (# MP281319), Product Manufacturer
e) Northeast Alternatives, Inc. (# MR281314), Retailer
f) Temescal Wellness of Massachusetts, Inc. (# MR281309), Retailer
g) Temescal Wellness of Massachusetts, Inc. (# MR281588), Retailer
h) Theory Wellness Inc. (# MR281549), Retailer
6) Staff Recommendations on Provisional License Applications
a) Baked Bean, LLC (# MPN281406), Product Manufacturer
b) BCWC, LLC (# MRN281379), Retailer
c) Berkshire Welco, LLC (# MCN281317), Cultivation, Tier 5/Indoor
d) Garden Remedies, Inc. (# MCN281504), Cultivation, Tier 3/Indoor
e) Garden Remedies, Inc. (# MPN281381), Product Manufacturer
f) Herbology Group, Inc. (# MRN281679), Retailer
g) Sanctuary Medicinals, Inc. (# MRN281950), Retailer
h) Silver Therapeutics, Inc. (# MCN281359), Cultivation, Tier 3/Indoor
i) Silver Therapeutics, Inc. (# MRN281271), Retailer
j) The Caregiver-Patient Connection (# MCN281254), Cultivation, Tier 2/Indoor
k) The Green Lady Dispensary, Inc. (# MCN281443), Cultivation, Tier 1/Indoor
l) The Green Lady Dispensary, Inc. (# MPN281345), Product Manufacturer
m) The Green Lady Dispensary, Inc. (# MRN281427), Retailer
n) The Verb is Herb, LLC (# MRN281637), Retailer
o) Viridis Analytics, LLC—d/b/a Evio Labs Massachusetts (# ILN281277), Independent
Testing Laboratory
7) Commission Discussion and Votes
a) Interdepartmental Service Agreement for the Transfer of the Medical Marijuana Program
b) 2019 Regulatory Timeline
c) Executive Director Authorization for Contract Modification
d) Office Space Procurement
i) Satellite Office – Project No. 201845000.1
e) Updated Guidance on Disproportionate Impact and Diversity Plans
8) New Business that the Chairman did not anticipate at time of posting
9) Next Meeting Date
Notice of Executive Session
Under the Open Meeting Law, G.L. c. 30A, § 21(a)(4) and (7) and the Public Records Law, G.L. c. 66, and the exemptions set forth in G.L. c. 4, § 7(26)(a), (f) and (n), the Commission may enter into executive session on the following agenda items:
1) to discuss provisional licensees’ qualifications for final licensure, including, but not limited to, the Commission staff’s strategies for reviewing, inspecting, and monitoring the proposed security plans of the Marijuana Establishment and for the marijuana and marijuana products
